Research & Development



  一個下人小廝跟丫鬟私奔不算大事,只要掩蓋一下,下一個禁口令,就什麼事都沒有了。 第四十九章 等不及長大caoporo   “哼!都丟盔棄甲了,要是在戰場,你會被砍頭的!”超碰免费视频 第四十八章 一入侯門深似海   放到現在,雲瑯唯恐漢人不懂得如何致富,哪里會嫌棄田氏賺錢的花樣多呢?青青青草免费超碰   “沒錯,就住在雲氏,一天天的衰老,要不是霍光打斷了何愁有的死亡路,這時候早死了。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo